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The occlusion of middle cerebral artery (MCA) is the most
common cause of ischemic stroke (Shi et at., 2010). The
MCA is one of three major paired arteries that supply the
brain with blood, and it is the largest branch of the internal
carotid artery. The MCA supplies blood to an extremely
large portion of brain: part of frontal lobe, lateral surface of
temporal and parietal lobes (DeLong, 1973).
It is known that occlusion of a large cerebral artery such as
the middle cerebral artery M1 segment can lead to severe
damage of the brain or result even in death. Cases of the
whole MCA territory involvement have been often de-
scribed in the literature; the neurological deterioration can
occur rapidly within 24 hours of symptom onset and has
been termed “malignant MCA infarction” (Treadwell and
Thanvi, 2010). However, there are few papers with discus-
sion of M1 MCA infarction when symptoms are not so se-
vere. Also, there has been no review about the situation in
Latvia on patients with MCA M1 occlusion.
The aim of this study was to prepare a review of patients
with M1 MCA infarction in patients treated in the Pauls
Stradiòð Clinical University Hospital and to compare the
outcome and efficiency of the used treatment.
A single-centre study was performed. It was a retrospective
analysis of ischemic stroke patient data from the Latvian
Stroke Register. A special questionnaire was obtained for
each patient, which included different parameters of pati-
ent’s neurological status, imaging and therapy.
The data of all patients who were hospitalised in Pauls Stra-
diòð Clinical University Hospital at the Department of Neu-
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The occlusion of middle cerebral artery (MCA) is the most common cause of ischemic stroke.
A retrospective single centre analysis of ischemic stroke was conducted using data from the Lat-
vian Stroke Register in the period from January 2013 till December 2014. The study included 478
patients who had confirmed MCA occlusion using computed tomography angiography (CTA). Half
of the patients were males — 237 (49.6%), average age 69.51, average age of females was
74.58 years. Cardioembolic stroke was the most common cause of MCA M1 segment occlusion
in 294 (61.5%) cases. Small cerebral artery occlusion was not a cause of M1 MCA occlusion.
The reperfusion therapy group consisted of 209 patients and the conservative therapy group of
269 patients. Both groups presented similar neurological status when they were admitted to hos-
pital. However, the reperfusion therapy group had better neurological status (NIHSS 6.82) than in
the conservative therapy group (NIHSS 8.2) at the time period when patients were discharged
from hospital (p < 0.05). There were more cases of good functional outcome (39.2%) and less of
poor (34.5%) in the reperfusion group, as well as less mortality — 7.6%. Middle cerebral artery
(MCA) is the most common site of stroke and the most common cause of its occlusion is cardi-
oembolism. There is high incidence of recurrence of stroke due to M1 MCA occlusion. Both
groups presented a similar neurological status on admission, but more improvement was seen in
the reperfusion therapy group after discharge of patients from hospital. The functional outcome
was also better in the reperfusion therapy group.
Key words: ischemic stroke, middle cerebral artery, computed tomography angiography,
reperfusion therapy, conservative therapy.
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S h o r t C o m m u n i c a t i o n
rology during the period from January 2013 till December
2014 with diagnosis ischemic stroke were reviewed. During
this time, 2179 patients were admitted with diagnosis
ischemic stroke. Of them, 1656 (75%) had cerebral infarc-
tion of the middle cerebral artery.
The subtypes of cerebral infarction were defined by TOAST
(Trial of ORG 10172 in Acute Stroke Treatment) criteria
(Adams et al., 1993).
The neurological status of patients was evaluated using the
National Institute of Health Stroke Scale (NIHSS) at the
time when they were admitted as well as when they were
discharged from hospital. Besides NIHSS, the modified
Rankin Scale (mRS) was used and the functional outcome
was defined as ’’good’’ (mRS 0-2), ’’moderate’’ (mRS 3),
and ’’poor’’ (mRS 4-5).
The data were summarised using descriptive statistics: aver-
age, percentage standard deviation with median range. Inde-
pendent variables like NIHSS and functional outcome
(mRS) were analysed using the T test and chi-square test.
All statistical analyses were performed using Windows Ex-
cel 2010. A p-value < 0.05 was considered statistically sig-
nificant.
MCA occlusion was confirmed in 478 patients by using
computed tomography angiography (CTA). Average age of
patients was 72.06 (SD +/ –10.07) years. Half of the pa-
tients were males — 237 (49.6%), average age 69.51 (SD ±
9.77), average age of females was 74.58 (SD ± 9.71) years
(Table 1).
Using TOAST criteria the most common cause of M1 MCA
occlusion was cardioembolic stroke in 294 (61.5%) cases.
The second most common cause was stroke due to large ar-
tery atherothrombosis in 138 (28.9%) cases. Small cerebral
artery occlusion was not a cause of M1 MCA occlusion
(Table 2).
Patients were divided into two groups according to the used
therapy. The reperfusion therapy group consisted of 209
(43.7%) patients who were admitted in a therapeutic time
window and had no contraindications for therapy. The other
group consisted of 269 (56.3%) patients who received con-
servative therapy.
One hundred twenty four (59.3%) patients in the reperfu-
sion therapy group received intravenous thrombolysis, 58
(27.8%) patients received mechanical thrombectomy and 27
(12.9%) patients had combined reperfusion therapy.
On admission there was no significant difference in the se-
verity of the neurological status between the reperfusion
and conservative therapy grous. Average NIHSS was 13.64
± 6.4 in the reperfusion therapy group, and 12.73 ± 6.31 for
patients who did not receive reperfusion therapy (p <
0.140).
There was a significant improvement of the neurological
status in both groups when patients were discharged from
hospital. The reperfusion therapy group had a better neuro-
logical status (NIHSS 6.82 ± 5.31) than in the conservative
therapy group (NIHSS 8.2 ± 6.23 (p < 0.04998) (Table 3).
There was also a significant improvement in the functional
outcome in patients who received reperfusion therapy.
There were more patients with good functional outcome
(mRS 0–2) in the reperfusion therapy group (39.2%) and
less patients with poor functional outcome (mRS 4–5 in
34.5% of patients). Also, the mortality rate was lower in the
reperfusion therapy group — 7.6% (p < 0.01) (Table 4).
In Europe, mean age of stroke patients is 71.8 years for
males and 76 years for females (Appelros et al., 2009). In
this study the mean age for males was 69.51 and for females
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T a b l e 1
BASELINE PATIENT CHARACTERISTICS
n = 478 (%) Mean ± SD (min –
max)
Male 237 (49.6%)
Age, years 69.51 ± 9.77 (32–91)
Female 241 (50.4%)
Age, years 74.58 ± 9.71 (38–91)
AH 394 (82.4%)
AF 272 (56.9%)
Previous TIA 8 (1.7%)
Previous CI 176 (3.8%)
Average days spent in hospital 10.61 ±5.04 (1–43)
Reperfusion therapy 209 (43.7%)
AH – arterial hypertension, AF – atrial fibrillation, TIA – transitory
ischemic attack, CI – cerebral infarction
T a b l e 2
SUBTYPES OF ISCHEMIC STROKE OF PATIENTS WITH M1 MCA
OCCLUSION
n = 478 (%)
Large artery atherosclerosis 138 (28.9%)
Cardioembolism 294 (61.5%)
Small artery occlusion 0
Other causes 10 (2.1%)
Undetermined causes 36 (7.5%)
T a b l e 3
AVERAGE NIHSS IN PATIENT GROUPS ON ADMISSION AND AT







13.64 ±6.41 12.73 ± 6.31 p > 0.140
NIHSS on discharge
mean ±SD
6.82 ±5.31 8.2 ± 6.23 p < 0.05
p < 0.00001 p < 0.00001
— 74.58 years. The mean age for patients in our study was
similar to the average in Europe.
This study showed that the most common cause of M1
MCA occlusion was cardioembolism — 61.5% of cases.
The literature on stroke epidemiology provides differing
data on incidence of stroke causes. There are studies that
show large artery atherothrombosis as the main cause of
stroke, even in 50% of cases (Murtagh and Smalling, 2006;
Ferro, 2003). Cardioembolic stroke was present only in
14–30 % of cases in some studies (Ferro, 2003; Arboix and
Alio, 2010; 2012). However, in more recent published stud-
ies cardioembolic stroke has been pointed out as the main
cause for ischemic stroke (Hannon et al., 2009; Marnane et
al., 2010; Palm et al., 2012). The diverse data of incidence
of stroke causes can be associated with various patient pools
that are analysed. In our study, we analysed only patients
with M1 MCA occlusion, and it is known that cardioembo-
lism most often causes occlusion of large vessels.
Recurrent stroke is highly prevalent among stroke survivors
and is a major cause of morbidity and mortality in these pa-
tients. Several studies have shown that 9–14 % of stroke pa-
tients experienced recurrence within two years after the
initial stroke (Lee et al., 2015). Our study showed higher in-
cidence of recurrent stroke — 38.5%. Probably one of the
reasons could be that the patient group consisted of those
with large artery occlusion and more than half of strokes
were due to cardioembolism, which had higher incidence of
recurrence.
Patients with M1 MCA occlusion, who received reperfusion
therapy, presented a slightly more severe neurological defi-
cit than those patients who received conservative therapy.
This slight difference of severity of neurological status can
be due to the collateral system of blood vessels. This was
not reviewed in this study, but there are a many papers that
show the importance of the artery collateral system for good
outcome in patients with ischemic stroke (Nayak et al.,
2010; Shi et al., 2010; Rohan et al., 2014). More recent
studies indicate the importance of choosing correct treat-
ment options for patients with large vessel occlusions, and
point out the effectiveness of combined reperfusion therapy
(Campbell et al., 2015; Goyal et al., 2015). In our study,
reperfusion therapy was received by 43.7% of patients and
combined therapy was used in 12.9% of cases. There was
better functional outcome in patients who received reper-
fusion therapy than in patients who received conservative
therapy. Therefore, proper evaluation of the neurological
status, indications and contraindications for different proce-
dures are the main aspect in benefiting good outcome for
the patient.
The middle cerebral artery (MCA) is the most common site
of stroke and the most common cause of its occlusion is due
to cardioembolism. There is high incidence of recurrence of
stroke due to M1 MCA occlusion. Both groups, reperfusion
and conservative therapy groups, presented similar neuro-
logical status on admission, but more improvement was
seen in the reperfusion therapy group after discharge of pa-
tients from the hospital. The functional outcome was also
better in the reperfusion therapy group.
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IÐÇMISKS INSULTS SAKARÂ AR ARTERIA CEREBRI MEDIA M1 SEGMENTA OKLÛZIJU: INSULTA REÌISTRA DATI
Iðçmisks insults visbieþâk notiek vidçjâs cerebrâlâs artçrijas apasiòoðanas baseinâ. Tika veikts retrospektîvs Insulta reìistra datu pçtîjums.
Pçtîjumam tika atlasîti un apstrâdâti pacientu dati laika periodâ no 2013. gada janvâra lîdz 2014. decembrim. Datu analîzei tika atlasîti 478
pacienti, kuriem ar angiogrâfijas metodi, bija apstiprinâta ACM oklûzija. Puse no pacientiem bija vîrieði 237 (49,6%) ar vidçjo vecumu
69,51 gadi, sievietçm vidçjais vecums bija 74,58 gadi. Bieþâkais insulta cçlonis bija kardioembolija — 294 (61, 5%) gadîjumos. Sîko
asinsvadu saslimðana nebija kâ cçlonis ACM M1 segmenta oklûzijas gadîjumâ. Reperfûzijas terapiju saòçma 209 (43,7%) pacienti.
Iestâjoties neiroloìiskais stâvoklis abâs grupâs bija lîdzîgs, taèu izrakstoties lielâks uzlabojums bija reperfûzijas terapijas grupâ NIHSS 6,82
salîdzinot ar konservatîvas terapijas grupu — NIHSS 8,2 (SD ± 6,23) (p < 0,05). Izrakstoties pacientu funkcionâlais stâvoklis bija labâks
reperfûzijas grupâ, mRS 0–2 bija 39,2% gadîjumu, kâ arî slikts funkcionâlais iznâkums (mRS 4–5) bija sastopams retâk – tikai 34,5%
gadîjumu. Mirstîba arî bija zemâka reperfûzijas grupâ — 7,6%, salîdzinot ar konservatîvâs terapijas grupu – 13,4%. Bieþâkais cçlonis
ACM M1 segmenta oklûzijas insultam ir kardioembolija. Pacientiem ir liela atkârtotu insultu incidence. Iestâjoties reperfûzijas terapijas un
konservatîvas terapijas grupu pacientiem neiroloìiskais stâvoklis bija lîdzîgs. Taèu reperfûzijas grupâ pacientiem izrakstoties bija
ievçrojamâks uzlabojums novçrtçjot neiroloìisko stâvokli. Arî funkcionâlais stâvoklis izrakstoties bija labâks pacientiem, kas saòçma
reperfûzijas terapiju.
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